Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Introduction Cytokine Release Syndrome (CRS) is an immune system overreaction triggered by therapies like immunotherapy or CAR-T cell treatment. It prompts an influx of cytokines, causing symptoms ranging from fever to potentiall..
Patients undergoing outpatient CAR T-cell therapy for cancer must be cared for by a multidisciplinary team that includes nurse coordinators, according to a poster presented at the 49th Annual Oncology Nursing Society Conference. ..
Introduction CAR T cell therapy, an innovative form of immunotherapy, has demonstrated exceptional efficacy in the treatment of specific tumors by leveraging the potency of a patient's own immune system. Recently, scientists have..
Feb 2024: China's pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy for multiple myeloma, a devastatin..
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment? Find out and begin your personalized journey to cancer recovery. He..
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy uses a patient's own immune cells and genetically modifies them to target and des..
Květen 2023: Terapie T-buněk chimérickým antigenním receptorem (CAR) je inovativním vývojem v oblasti individualizované terapie rakoviny. Vlastní T-buňky pacienta jsou během výrobního procesu geneticky modifikovány tak, aby exprimovaly a..
Březen 2023: První kapitola memoárů Sama Neilla by byla obrovským šokem pro někoho, kdo o ní neměl žádné předchozí znalosti. Začíná to dost legračně: skvělá historka o tom, že jeho dcera Elena byla vyslýchána kvůli otcově jo...
Březen 2023: Stručné shrnutí: Účelem této klinické studie je zjistit, zda anti-MESO antigenní receptor CAR T-buněčná terapie může být použita k léčbě epiteliálního karcinomu vaječníků, který se vrátil nebo přestal reagovat na jiné.